A thread lift maintenance schedule is the difference between a practice that does threads and a practice that has thread patients. Most injectors treat the procedure as a discrete event: place, follow up, done. Tatiana Sarmiento, faculty at Empire Medical Training, runs it as a program with a booked endpoint built in from the start:
"From six months to eighteen is when I tell my patient to come back and see me to do a reassessment, and maybe add some more threads for the longevity of the lift that I provided to them. So the maintenance, the results, vary by patient's vector plan, thread type, and aftercare."
Two structural decisions are contained in that. The reassessment is scheduled, not triggered by the patient noticing something. And the expected action at that appointment is additive, not a repeat of the original treatment. Both are worth getting right, because both are commonly got wrong in ways that cost the practice and the patient.
These intervals reflect Tatiana Sarmiento's clinical practice as taught in Empire Medical Training's hands-on curriculum. Technique is learned under supervision; this article is educational and is not a substitute for training.
Why patient-triggered recall fails
Left to themselves, thread patients come back at one of two moments, and both are the wrong one.
Too early: the crossover. The first time a patient perceives loss is during the handover between suture absorption and the maturing collagen response, when swelling has gone and the biological result has not fully arrived. This is the moment they feel the strongest urge to act — and it is the worst moment to act, because the tissue state you would be assessing is transitional and about to improve on its own. Treating here means placing threads against a reading that is about to be invalidated. The mechanism of that dip is a separate topic; the scheduling consequence is that the patient's own sense of timing is systematically wrong at this point.
Too late: baseline. The other pattern is the patient who returns once the result has completely gone, often a year or more after the fact. Now you are not maintaining anything. You are performing the original treatment again, on a face that has continued to age in the interim, and the patient experiences it as having bought the same thing twice.
The scheduled window exists to land between those two. It is placed after the collagen response has fully declared itself and before the result has fully gone, which is the only interval in which the word "maintenance" is doing honest work.
Additive versus starting over
The distinction Sarmiento draws — "add some more threads for the longevity of the lift" — is not a billing convenience. It is a different clinical situation.
At the reassessment window, a well-treated patient has tissue that has already responded: collagen was laid down along the original tracks and the envelope is not the envelope you started with. Threads added into that bed are working with an existing scaffold, supplementing a result that is still partly present.
A patient who has returned to baseline offers none of that. The original response has remodelled away, the face has aged further, and the new plan has to be built from scratch — usually with more threads, on a face that is now closer to the selection boundaries described in patient selection than it was the first time.
Practically, this changes three things:
The plan. Additive work targets where the result has softened, which is rarely uniform across the face. It is a supplement, not a repeat, and the second plan should look different from the first.
The conversation. "We are topping up what is still working" is a different and more honest proposition than "we are doing it again."
The candidacy question. A patient who has drifted into heavier laxity in the intervening period may no longer be a candidate. Time passes between treatments, and re-treating a returning patient without re-running the selection assessment is one of the easier ways to produce a poor outcome in someone who succeeded the first time.
Setting the individual interval
Six to eighteen months is a wide range because the drivers are genuinely determinative, not because the figure is vague. Sarmiento names four, and each moves the interval predictably.
Thread type. Cog threads have a mechanical contribution that begins declining at placement and a collagen contribution that behaves like any other thread's. Mono and screw threads have only the second. That difference in profile is the single biggest driver of when the result will need attention, and a plan built predominantly on mechanical lift will generally need reassessment earlier than one built on stimulation.
Vector plan. A vector carrying significant load against gravity is working harder than one placed in well-supported tissue, and load shortens functional life. Where the original plan asked a lot of a small number of vectors, review earlier.
The patient's own tissue. Tissue weight, skin quality and the rate at which that individual's face is changing all shift the interval. A patient near the upper limit of what threads can hold will show softening sooner than one treated early in their descent.
Aftercare. Sarmiento names this explicitly as a variable in the outcome. Patients who follow the post-procedure instructions and those who do not are not on the same curve, and it is reasonable to note adherence at the time so the interval can be set with it in mind.
A fifth, practical one: whether this was a first treatment or an additive one. Results built on an existing collagen bed behave differently from a first pass, and the interval should be set from what you observe rather than copied forward.
The operational discipline is to name the interval at the end of the procedure, in the notes and to the patient, rather than defaulting to a standard figure. "I'll see you at nine months" is a clinical judgement. "Come back in a year" is a habit.
The full touchpoint calendar
The reassessment is the endpoint of a sequence, not an isolated appointment. A thread program has five contacts, and each has a defined purpose.
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Aesthetic & Injectable Training courses — live patients, expert faculty, and ongoing mentorship.
| Contact | Purpose |
|---|---|
| Around day 5 | Confirm bruising and swelling are settling as expected |
| Around day 14 | The discriminator point — tenderness, dimpling and tightness should be improving. Anything persisting past this window is a clinical finding, not recovery |
| The crossover | A counselling milestone, not a treatment visit. The patient has been warned; this contact confirms the warning was accurate |
| Weeks 6–12 | Collagen phase review. Density errors from crowded layouts declare themselves here, and this is the first honest look at the result |
| 6–18 months | Full reassessment. Add, hold, redirect or decline |
The crossover contact is the one most often omitted and the one with the highest return. A patient who was warned about the drop and then hears nothing when it arrives concludes the warning was a hedge. A short scheduled contact converts the same event into evidence that you knew what would happen.
What a reassessment actually consists of
Four inputs, in this order.
Standardised photography, compared to the pre-treatment set. Same position, same lighting, same distance. Memory is not evidence, and neither is the patient's. Comparative photography is the only way to distinguish a result that has softened from a result the patient has simply stopped noticing — which is common, because faces normalise to the observer.
A manual reposition assessment. Upright, with a fingertip along the original vectors. This tells you how much of the correction is still being held and how much force the tissue now requires — which is the same test used in the original selection assessment, repeated on a changed face.
The patient's subjective report, separated from their request. What they have noticed and when is data. What they want done is a separate conversation, taken after you have formed your own view.
A re-run of candidacy. The exclusions that applied at the first consultation apply again. Tissue heaviness, skin quality and expectation can all have changed.
Four legitimate outcomes
A program is not a subscription, and the reassessment has to be able to end in something other than a procedure. Four outcomes should be genuinely available:
Add. The result has softened, the tissue still holds, additive threads targeted at where it has softened.
Hold. The result is still adequate. Re-book the reassessment and do nothing today. This outcome has to be real and offered without embarrassment — a clinician who cannot say "nothing today" has a recall system that is really a sales schedule, and patients recognise it faster than practices expect.
Redirect. The face has changed in a way threads no longer address — skin quality has declined, volume deficit now dominates, the descent has become heavier. Collagen stimulation or a biostimulator approach may now be the better answer, and the combination sequencing is its own decision.
Decline. The patient has crossed a selection boundary. The right answer is the same as it would be for a new patient presenting that way, and prior successful treatment does not create an entitlement to further treatment.
The operational side
Programs fail on administration more often than on clinical judgement. Three things make the difference:
Someone owns the recall. If the reassessment lives only in the patient's memory, it does not exist. It should be booked, or at minimum diarised with an owner, before they leave.
The plan is retrievable. The vector map, the thread types, the layout and the photographs must be findable a year later by whoever sees the patient. An additive plan built without sight of the original is guesswork.
The interval is recorded as a decision with a reason. "Nine months — cog-dominant plan, heavy load on the lateral vectors" is a note the next clinician can use. A bare date is not.
Patients also ask the duration question directly, and the honest answer is the range with its drivers attached rather than a single figure — that framing is covered in how long a thread lift lasts. Clinicians building thread work into a structured practice will find the technique and the planning taught together in Empire's Advanced PDO Thread Lift Training.
Frequently Asked Questions
When should a thread lift patient come back for reassessment?
Tatiana Sarmiento schedules reassessment between six and eighteen months after treatment, with the individual interval set by the thread types used, the load on the vector plan, the patient's own tissue and their aftercare adherence. The interval should be named and recorded at the end of the procedure rather than left to the patient to initiate.
Can you add threads to a face that already has PDO threads?
Yes, and that is the intended action at reassessment. Adding into a tissue bed that has already produced a collagen response is a different proposition from treating a face that has returned to baseline — the additive plan supplements what is still working and should target where the result has softened rather than repeat the original layout.
Why not just wait until the patient notices the result has gone?
Because by then you are repeating the original treatment on a face that has aged further, rather than maintaining a result. Patients also tend to report loss at the wrong moment — during the transitional dip between suture absorption and the maturing collagen response, when the tissue state is about to improve on its own.
Does every reassessment appointment mean more threads?
No, and it should not. Legitimate outcomes include adding threads, holding and re-booking, redirecting to a different modality if the face has changed in a way threads no longer address, and declining if the patient has crossed a selection boundary. A recall system in which the only available outcome is a procedure is a sales schedule rather than a clinical one.
Disclaimer
This article reflects the clinical opinions and experience of Tatiana Sarmiento, Faculty, Empire Medical Training, an independent faculty member contributing to Empire Medical Training's curriculum. The views expressed are the author's own and do not necessarily represent those of Empire Medical Training.
It is professional education, not medical advice, and is no substitute for hands-on training or independent clinical judgment. Licensed clinicians remain responsible for their own patient selection, technique and outcomes, for verifying current product labelling, and for practising within their scope and applicable law. Empire Medical Training accepts no liability for reliance on this content.
